Table 2.
Demographic and microbiological characteristics of TB patients before and during COVID-19
| Variables | Pre-COVID-19 period | COVID-19 period | Percentage difference between periods (increase-decrease) | p* | ||
|---|---|---|---|---|---|---|
| n = 172 | n = 148 | |||||
|
Age (years) Mean ± SD(median (IQR)) |
53.44 ± 20.46 (57.0(38.0–69.0)) | 48.74 ± 21.73 (53.0(30.0–65.0)) | 0.047** | |||
| n | %a | n | %a | 0.196 | ||
| Age group (years) | ||||||
| < 18 | 8 | 4.7 | 12 | 8.1 | 50.00% | |
| 18–64 | 103 | 59.9 | 95 | 64.2 | −7.77% | |
| > 65 | 61 | 35.5 | 41 | 27.7 | −32.79% | |
| Gender | 0.751 | |||||
| Male | 105 | 61.0 | 88 | 59.5 | −16.19% | |
| Female | 67 | 39.0 | 60 | 40.5 | −10.45% | |
| Country of origin | 0.235 | |||||
| Turkey | 155 | 90.1 | 127 | 85.8 | −18.06% | |
| Others (Syria, Iraq, Iranian et al..) | 17 | 9.9 | 21 | 14.2 | 23.53% | |
| TB site | 0.717 | |||||
| Pulmonary | 120 | 69.8 | 106 | 71.6 | −11.67% | |
| Extra-pulmonary | 52 | 30.2 | 42 | 28.4 | −19.23% | |
| Patient type | 0.773 | |||||
| New | 162 | 94.2 | 138 | 93.2 | −14.81% | |
| Relapse | 8 | 4.7 | 9 | 6.1 | 12.50% | |
| Patient coming from treatment abandonment or failure | 2 | 1.2 | 1 | 0.7 | −50.00% | |
| Multi-drug resistance (MDR) results | 0.448 | |||||
| No | 94 | 96.9 | 69 | 98.6 | −26.60% | |
| Yes | 3 | 3.1 | 1 | 1.4 | −66.67% | |
| TB diagnosis | 0.070 | |||||
| Microscopy (smear) positive | 49 | 29.1 | 46 | 30.4 | −6.12% | |
| Culture positive | 48 | 27.9 | 42 | 28.4 | −12.50% | |
| Clinical or radiological positive | 30 | 16.9 | 25 | 17.6 | −16.67% | |
| Histopathological positive | 45 | 26.2 | 29 | 19.6 | −35.56% | |
*The Chi-Square Test, **Student-T test, acolumn percentage